{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:18:43Z","timestamp":1794647923769,"version":"4.9.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10356-z","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:33:59Z","timestamp":1779528839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approach"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-7471","authenticated-orcid":false,"given":"Giacomo","family":"Ducci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Ciufolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Campioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8019-6767","authenticated-orcid":false,"given":"Simone","family":"Ponzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Giovanni","family":"Galuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"D\u2019Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrunda","family":"Satasiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5999-7613","authenticated-orcid":false,"given":"Elisa","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2473-3535","authenticated-orcid":false,"given":"Chiara","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Vago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Bonanomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2319-7884","authenticated-orcid":false,"given":"Andrea","family":"Morrione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4198-9620","authenticated-orcid":false,"given":"Rocco","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5012-1714","authenticated-orcid":false,"given":"Daniel Oscar","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8690-2587","authenticated-orcid":false,"given":"Marco","family":"Vanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-9820","authenticated-orcid":false,"given":"Greta","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-7671","authenticated-orcid":false,"given":"Elena","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"10356_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca. Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"Ca. Cancer J. Clin."},{"key":"10356_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","volume":"374","author":"DS Kaufman","year":"2009","unstructured":"Kaufman, D. S., Shipley, W. U. & Feldman, A. S. Bladder cancer. Lancet 374, 239\u2013249 (2009).","journal-title":"Lancet"},{"key":"10356_CR3","first-page":"532","volume":"34","author":"CJ Down","year":"2016","unstructured":"Down, C. J., Nair, R. & Thurairaja, R. Bladder cancer. Surg 34, 532\u2013539 (2016).","journal-title":"Surg"},{"key":"10356_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/iju.13509","volume":"25","author":"Y Fujii","year":"2018","unstructured":"Fujii, Y. Prediction models for progression of non-muscle-invasive bladder cancer: a review. Int. J. Urol. 25, 212\u2013218 (2018).","journal-title":"Int. J. Urol."},{"key":"10356_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eururo.2024.09.012","volume":"87","author":"R Li","year":"2025","unstructured":"Li, R. et al. FGFR inhibition in urothelial carcinoma. Eur. Urol. 87, 110\u2013122 (2025).","journal-title":"Eur. Urol."},{"key":"10356_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran, L., Xiao, J.-F., Agarwal, N., Duex, J. E. & Theodorescu, D. Advances in bladder cancer biology and therapy. Nat. Rev. Cancer 21, 104\u2013121 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"10356_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t, L. et al. Bladder cancer. Nat. Rev. Dis. Prim. 9, 58 (2023).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10356_CR8","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ng.2798","volume":"45","author":"G Guo","year":"2013","unstructured":"Guo, G. et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat. Genet. 45, 1459\u20131463 (2013).","journal-title":"Nat. Genet."},{"key":"10356_CR9","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/cancers14071795","volume":"14","author":"J Thomas","year":"2022","unstructured":"Thomas, J. & Sonpavde, G. Molecularly targeted therapy towards genetic alterations in advanced bladder cancer. Cancers 14, 1795 (2022).","journal-title":"Cancers"},{"key":"10356_CR10","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/cancers14061416","volume":"14","author":"K Szklener","year":"2022","unstructured":"Szklener, K., Chmiel, P., Michalski, A. & Ma\u0144dziuk, S. New directions and challenges in targeted therapies of advanced bladder cancer: the role of FGFR inhibitors. Cancers 14, 1416 (2022).","journal-title":"Cancers"},{"key":"10356_CR11","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1158\/1078-0432.CCR-16-2267","volume":"23","author":"NM Hahn","year":"2017","unstructured":"Hahn, N. M. et al. A phase II trial of dovitinib in BCG-unresponsive urothelial carcinoma with FGFR3 mutations or overexpression: Hoosier Cancer Research Network trial HCRN 12-157. Clin. Cancer Res. 23, 3003\u20133011 (2017).","journal-title":"Clin. Cancer Res."},{"key":"10356_CR12","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1016\/j.ejca.2014.10.013","volume":"50","author":"MI Milowsky","year":"2014","unstructured":"Milowsky, M. I. et al. Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma. Eur. J. Cancer 50, 3145\u20133152 (2014).","journal-title":"Eur. J. Cancer"},{"key":"10356_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJMoa1817323","volume":"381","author":"Y Loriot","year":"2019","unstructured":"Loriot, Y. et al. Erdafitinib in locally advanced or metastatic urothelial carcinoma. N. Engl. J. Med. 381, 338\u2013348 (2019).","journal-title":"N. Engl. J. Med."},{"key":"10356_CR14","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1158\/2159-8290.CD-12-0569","volume":"3","author":"MT Herrera-Abreu","year":"2013","unstructured":"Herrera-Abreu, M. T. et al. Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3 -mutant cancer. Cancer Discov. 3, 1058\u20131071 (2013).","journal-title":"Cancer Discov."},{"key":"10356_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00417-5","volume":"7","author":"Z Wang","year":"2023","unstructured":"Wang, Z., Muthusamy, V., Petrylak, D. P. & Anderson, K. S. Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR\/HDAC targeted therapy. NPJ Precis. Oncol. 7, 70 (2023).","journal-title":"NPJ Precis. Oncol."},{"key":"10356_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1200\/JCO.21.02303","volume":"41","author":"CN Sternberg","year":"2023","unstructured":"Sternberg, C. N. et al. FORT-1: Phase II\/III study of rogaratinib versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma selected based on FGFR1\/3 mRNA expression. J. Clin. Oncol. 41, 629\u2013639 (2023).","journal-title":"J. Clin. Oncol."},{"key":"10356_CR17","doi-asserted-by":"publisher","first-page":"e0231877","DOI":"10.1371\/journal.pone.0231877","volume":"15","author":"PCC Liu","year":"2020","unstructured":"Liu, P. C. C. et al. INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models. PLoS ONE 15, e0231877 (2020).","journal-title":"PLoS ONE"},{"key":"10356_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.annonc.2022.02.001","volume":"33","author":"V Subbiah","year":"2022","unstructured":"Subbiah, V. et al. FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF\/FGFR alterations and advanced malignancies. Ann. Oncol. 33, 522\u2013533 (2022).","journal-title":"Ann. Oncol."},{"key":"10356_CR19","doi-asserted-by":"publisher","first-page":"102530","DOI":"10.1016\/j.ctrv.2023.102530","volume":"115","author":"CM Ascione","year":"2023","unstructured":"Ascione, C. M. et al. Role of FGFR3 in bladder cancer: treatment landscape and future challenges. Cancer Treat. Rev. 115, 102530 (2023).","journal-title":"Cancer Treat. Rev."},{"key":"10356_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"10356_CR21","first-page":"327","volume":"36","author":"BL Woolbright","year":"2018","unstructured":"Woolbright, B. L., Ayres, M. & Taylor, J. A. Metabolic changes in bladder cancer. Urol. Oncol. Semin. Orig. Investig. 36, 327\u2013337 (2018).","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10356_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On the origin of cancer cells. Science 123, 309\u2013314 (1956).","journal-title":"Science"},{"key":"10356_CR23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"10356_CR24","doi-asserted-by":"publisher","first-page":"15787","DOI":"10.3390\/ijms242115787","volume":"24","author":"L Alberghina","year":"2023","unstructured":"Alberghina, L. The Warburg effect explained: integration of enhanced glycolysis with heterogeneous mitochondria to promote cancer cell proliferation. Int. J. Mol. Sci. 24, 15787 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"10356_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","volume":"39","author":"KC Patra","year":"2014","unstructured":"Patra, K. C. & Hay, N. The pentose phosphate pathway and cancer. Trends Biochem. Sci. 39, 347\u2013354 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"10356_CR26","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo, H. C., Yu, Y. C., Sung, Y. & Han, J. M. Glutamine reliance in cell metabolism. Exp. Mol. Med. 52, 1496\u20131516 (2020).","journal-title":"Exp. Mol. Med."},{"key":"10356_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer 122, 4\u201322 (2020).","journal-title":"Br. J. Cancer"},{"key":"10356_CR28","doi-asserted-by":"publisher","first-page":"e2253","DOI":"10.1038\/cddis.2016.105","volume":"7","author":"E Panieri","year":"2016","unstructured":"Panieri, E. & Santoro, M. M. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 7, e2253\u2013e2253 (2016).","journal-title":"Cell Death Dis."},{"key":"10356_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs, L. K. & DeBerardinis, R. J. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 17, 351\u2013359 (2015).","journal-title":"Nat. Cell Biol."},{"key":"10356_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell 13, 472\u2013482 (2008).","journal-title":"Cancer Cell"},{"key":"10356_CR31","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"10356_CR32","doi-asserted-by":"crossref","unstructured":"Iurlaro, R., Le\u00f3n-Annicchiarico, C. L. & Mu\u00f1oz-Pinedo, C. Regulation of Cancer Metabolism by Oncogenes and Tumor Suppressors 59\u201380 (2014).","DOI":"10.1016\/B978-0-12-416618-9.00003-0"},{"key":"10356_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.trecan.2016.06.002","volume":"2","author":"A Nagarajan","year":"2016","unstructured":"Nagarajan, A., Malvi, P. & Wajapeyee, N. Oncogene-directed alterations in cancer cell metabolism. Trends Cancer 2, 365\u2013377 (2016).","journal-title":"Trends Cancer"},{"key":"10356_CR34","doi-asserted-by":"crossref","unstructured":"Lee, S. Y. et al. Oncogenic metabolism acts as a prerequisite step for induction of cancer metastasis and cancer stem cell phenotype. Oxid. Med. Cell. Longev. 2018, 1027453 (2018).","DOI":"10.1155\/2018\/1027453"},{"key":"10356_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/pharmaceutics14061303","volume":"14","author":"C Navarro","year":"2022","unstructured":"Navarro, C. et al. Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches. Pharmaceutics 14, 1303 (2022).","journal-title":"Pharmaceutics"},{"key":"10356_CR36","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","volume":"35","author":"Y Xiao","year":"2023","unstructured":"Xiao, Y. et al. Emerging therapies in cancer metabolism. Cell Metab. 35, 1283\u20131303 (2023).","journal-title":"Cell Metab."},{"key":"10356_CR37","doi-asserted-by":"crossref","unstructured":"Lemberg, K. M., Gori, S. S., Tsukamoto, T., Rais, R. & Slusher, B. S. Clinical development of metabolic inhibitors for oncology. J. Clin. Invest. 132, e148550 (2022).","DOI":"10.1172\/JCI148550"},{"key":"10356_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2049-3002-1-20","volume":"1","author":"SC Dolfi","year":"2013","unstructured":"Dolfi, S. C. et al. The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab. 1, 20 (2013).","journal-title":"Cancer Metab."},{"key":"10356_CR39","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.3390\/cancers13246330","volume":"13","author":"A D\u2019Aloia","year":"2021","unstructured":"D\u2019Aloia, A. et al. RalGPS2 interacts with Akt and PDK1 promoting tunneling nanotubes formation in bladder cancer and kidney cells microenvironment. Cancers 13, 6330 (2021).","journal-title":"Cancers"},{"key":"10356_CR40","doi-asserted-by":"crossref","unstructured":"Koberstein, J. N. et al. Monitoring glycolytic dynamics in single cells using a fluorescent biosensor for fructose 1,6-bisphosphate. Proc. Natl. Acad. Sci. USA 119, e2204407119 (2022).","DOI":"10.1073\/pnas.2204407119"},{"key":"10356_CR41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/cancers12051119","volume":"12","author":"S Cassim","year":"2020","unstructured":"Cassim, S., Vu\u010deti\u0107, M., \u017ddralevi\u0107, M. & Pouyssegur, J. Warburg and beyond: the power of mitochondrial metabolism to collaborate or replace fermentative glycolysis in cancer. Cancers. 12, 1119 (2020).","journal-title":"Cancers."},{"key":"10356_CR42","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.3390\/ijms21218107","volume":"21","author":"G Petrella","year":"2020","unstructured":"Petrella, G., Ciufolini, G., Vago, R. & Cicero, D. O. The interplay between oxidative phosphorylation and glycolysis as a potential marker of bladder cancer progression. Int. J. Mol. Sci. 21, 8107 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"10356_CR43","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00204-020-02838-8","volume":"94","author":"JM Mat\u00e9s","year":"2020","unstructured":"Mat\u00e9s, J. M., Campos-Sandoval, J. A., de los Santos-Jim\u00e9nez, J. & M\u00e1rquez, J. Glutaminases regulate glutathione and oxidative stress in cancer. Arch. Toxicol. 94, 2603\u20132623 (2020).","journal-title":"Arch. Toxicol."},{"key":"10356_CR44","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/0008-5472.CAN-20-0617","volume":"81","author":"W Guo","year":"2021","unstructured":"Guo, W. et al. Dysregulated glutamate transporter SLC1A1 propels cystine uptake via Xc\u2212 for glutathione synthesis in lung cancer. Cancer Res. 81, 552\u2013566 (2021).","journal-title":"Cancer Res."},{"key":"10356_CR45","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale, J. W. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13, 572\u2013583 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"10356_CR46","doi-asserted-by":"publisher","first-page":"165841","DOI":"10.1016\/j.bbadis.2020.165841","volume":"1866","author":"AM Li","year":"2020","unstructured":"Li, A. M. & Ye, J. Reprogramming of serine, glycine and one-carbon metabolism in cancer. Biochim. Biophys. Acta - Mol. Basis Dis. 1866, 165841 (2020).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10356_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009337","volume":"18","author":"M Di Filippo","year":"2022","unstructured":"Di Filippo, M. et al. INTEGRATE: model-based multi-omics data integration to characterize multi-level metabolic regulation. PLOS Comput. Biol. 18, e1009337 (2022).","journal-title":"PLOS Comput. Biol."},{"key":"10356_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1005758","volume":"13","author":"C Damiani","year":"2017","unstructured":"Damiani, C. et al. A metabolic core model elucidates how enhanced utilization of glucose and glutamine, with enhanced glutamine-dependent lactate production, promotes cancer cell growth: the WarburQ effect. PLoS Comput. Biol. 13, 1\u201329 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"10356_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04967-6","volume":"23","author":"BG Galuzzi","year":"2022","unstructured":"Galuzzi, B. G., Vanoni, M. & Damiani, C. Combining denoising of RNA-seq data and flux balance analysis for cluster analysis of single cells. BMC Bioinforma. 23, 445 (2022).","journal-title":"BMC Bioinforma."},{"key":"10356_CR50","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540\u2013556.e25 (2017).","journal-title":"Cell"},{"key":"10356_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/sj.bjc.6606016","volume":"104","author":"FR Lamont","year":"2010","unstructured":"Lamont, F. R. et al. Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo. Br. J. Cancer 104, 75\u201382 (2010).","journal-title":"Br. J. Cancer"},{"key":"10356_CR52","first-page":"49","volume":"87","author":"S Siracusano","year":"2020","unstructured":"Siracusano, S., Rizzetto, R. & Porcaro, A. B. Bladder cancer genomics. Urol. J. 87, 49\u201356 (2020).","journal-title":"Urol. J."},{"key":"10356_CR53","first-page":"313","volume":"36","author":"F Audenet","year":"2018","unstructured":"Audenet, F., Attalla, K. & Sfakianos, J. P. The evolution of bladder cancer genomics: what have we learned and how can we use it? Urol. Oncol. Semin. Orig. Investig. 36, 313\u2013320 (2018).","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10356_CR54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12672-024-01173-z","volume":"15","author":"DE Bogale","year":"2024","unstructured":"Bogale, D. E. The roles of FGFR3 and c-MYC in urothelial bladder cancer. Discov. Oncol. 15, 295 (2024).","journal-title":"Discov. Oncol."},{"key":"10356_CR55","doi-asserted-by":"crossref","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","DOI":"10.1126\/science.aaw5473"},{"key":"10356_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01957-4","volume":"22","author":"M Liaghat","year":"2024","unstructured":"Liaghat, M. et al. The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors. Cell Commun. Signal. 22, 575 (2024).","journal-title":"Cell Commun. Signal."},{"key":"10356_CR57","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1111\/febs.14090","volume":"284","author":"M Sciacovelli","year":"2017","unstructured":"Sciacovelli, M. & Frezza, C. Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer. FEBS J. 284, 3132\u20133144 (2017).","journal-title":"FEBS J."},{"key":"10356_CR58","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","volume":"74","author":"C Raggi","year":"2021","unstructured":"Raggi, C. et al. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. J. Hepatol. 74, 1373\u20131385 (2021).","journal-title":"J. Hepatol."},{"key":"10356_CR59","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"10356_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.it.2024.05.006","volume":"45","author":"Y Agarwala","year":"2024","unstructured":"Agarwala, Y., Brauns, T. A., Sluder, A. E., Poznansky, M. C. & Gemechu, Y. Targeting metabolic pathways to counter cancer immunotherapy resistance. Trends Immunol. 45, 486\u2013494 (2024).","journal-title":"Trends Immunol."},{"key":"10356_CR61","doi-asserted-by":"publisher","first-page":"41706","DOI":"10.18632\/oncotarget.5991","volume":"6","author":"C Denise","year":"2015","unstructured":"Denise, C. et al. 5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits. Oncotarget 6, 41706\u201341721 (2015).","journal-title":"Oncotarget"},{"key":"10356_CR62","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.copbio.2020.02.013","volume":"63","author":"C Damiani","year":"2020","unstructured":"Damiani, C., Gaglio, D., Sacco, E., Alberghina, L. & Vanoni, M. Systems metabolomics: from metabolomic snapshots to design principles. Curr. Opin. Biotechnol. 63, 190\u2013199 (2020).","journal-title":"Curr. Opin. Biotechnol."},{"key":"10356_CR63","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/cancers12092624","volume":"12","author":"R Shah","year":"2020","unstructured":"Shah, R. & Chen, S. Metabolic signaling cascades prompted by glutaminolysis in cancer. Cancers 12, 2624 (2020).","journal-title":"Cancers"},{"key":"10356_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail, M., Jiang, C.-H. & Li, N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol. Cancer 23, 203 (2024).","journal-title":"Mol. Cancer"},{"key":"10356_CR65","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3892\/ijo.2020.5158","volume":"58","author":"S Pan","year":"2020","unstructured":"Pan, S., Fan, M., Liu, Z., Li, X. & Wang, H. Serine, glycine and one\u2011carbon metabolism in cancer. Int. J. Oncol. 58, 158\u2013170 (2020).","journal-title":"Int. J. Oncol."},{"key":"10356_CR66","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1096\/fj.202000767R","volume":"34","author":"P Marchetti","year":"2020","unstructured":"Marchetti, P., Fovez, Q., Germain, N., Khamari, R. & Kluza, J. Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells. FASEB J. 34, 13106\u201313124 (2020).","journal-title":"FASEB J."},{"key":"10356_CR67","doi-asserted-by":"crossref","unstructured":"Kacew, A. & Sweis, R. F. FGFR3 alterations in the era of immunotherapy for urothelial bladder cancer. Front. Immunol. 11, 57528 (2020).","DOI":"10.3389\/fimmu.2020.575258"},{"key":"10356_CR68","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1111\/cas.16333","volume":"115","author":"R Kamitani","year":"2024","unstructured":"Kamitani, R. et al. Tumor immune microenvironment dynamics and outcomes of prognosis in non-muscle-invasive bladder cancer. Cancer Sci. 115, 3963\u20133972 (2024).","journal-title":"Cancer Sci."},{"key":"10356_CR69","doi-asserted-by":"crossref","unstructured":"Liu, L. et al. KDM6A-ARHGDIB axis blocks metastasis of bladder cancer by inhibiting Rac1. Mol. Cancer 20, 77 (2021).","DOI":"10.1186\/s12943-021-01369-9"},{"key":"10356_CR70","doi-asserted-by":"crossref","unstructured":"Pang, K. et al. The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells. BMC Cancer 19, 225 (2019).","DOI":"10.1186\/s12885-019-5423-9"},{"key":"10356_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9122669","volume":"9","author":"V Pasquale","year":"2020","unstructured":"Pasquale, V. et al. Profiling and targeting of energy and redox metabolism in grade 2 bladder cancer cells with different invasiveness properties. Cells 9, 1\u201326 (2020).","journal-title":"Cells"},{"key":"10356_CR72","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/cells11050866","volume":"11","author":"G Campioni","year":"2022","unstructured":"Campioni, G. et al. An optimized workflow for the analysis of metabolic fluxes in cancer spheroids using Seahorse technology. Cells 11, 866 (2022).","journal-title":"Cells"},{"key":"10356_CR73","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbabio.2014.10.005","volume":"1847","author":"SA Mookerjee","year":"2015","unstructured":"Mookerjee, S. A., Goncalves, R. L. S., Gerencser, A. A., Nicholls, D. G. & Brand, M. D. The contributions of respiration and glycolysis to extracellular acid production. Biochim. Biophys. Acta - Bioenerg. 1847, 171\u2013181 (2015).","journal-title":"Biochim. Biophys. Acta - Bioenerg."},{"key":"10356_CR74","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1074\/jbc.M116.774471","volume":"292","author":"SA Mookerjee","year":"2017","unstructured":"Mookerjee, S. A., Gerencser, A. A., Nicholls, D. G. & Brand, M. D. Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements. J. Biol. Chem. 292, 7189\u20137207 (2017).","journal-title":"J. Biol. Chem."},{"key":"10356_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"10356_CR76","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"10356_CR77","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178\u2013192 (2013).","journal-title":"Brief. Bioinform."},{"key":"10356_CR78","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44, e71\u2013e71 (2016).","journal-title":"Nucleic Acids Res"},{"key":"10356_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinforma. 17, 483 (2016).","journal-title":"BMC Bioinforma."},{"key":"10356_CR80","unstructured":"Leek, J. T. et al. sva: Variable Analysis. Bioconductor (2022)."},{"key":"10356_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."},{"key":"10356_CR82","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084\u20132092 (2019).","journal-title":"Bioinformatics"},{"key":"10356_CR83","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10356_CR84","unstructured":"Ushey, K. & Wickham, H. renv: Project Environments. R package version 1.1.6 (2026)."},{"key":"10356_CR85","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.csbj.2020.04.008","volume":"18","author":"C Damiani","year":"2020","unstructured":"Damiani, C. et al. MaREA4Galaxy: metabolic reaction enrichment analysis and visualization of RNA-seq data within Galaxy. Comput. Struct. Biotechnol. J. 18, 993\u2013999 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10356_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005758","volume":"13","author":"C Damiani","year":"2017","unstructured":"Damiani, C. et al. A metabolic core model elucidates how enhanced utilization of glucose and glutamine, with enhanced glutamine-dependent lactate production, promotes cancer cell growth: the WarburQ effect. PLOS Comput. Biol. 13, e1005758 (2017).","journal-title":"PLOS Comput. Biol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10356-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10356-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10356-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:02:04Z","timestamp":1784970124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10356-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10356"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10356-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1014"}}